|
WTAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63724589441472E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40699674133771E-11 |
| Normal-vs-Stage2 |
4.13239997776316E-09 |
| Normal-vs-Stage3 |
2.11249906456601E-11 |
| Normal-vs-Stage4 |
3.30509997148454E-09 |
| Stage1-vs-Stage2 |
2.792500E-02 |
| Stage1-vs-Stage3 |
1.046830E-01 |
| Stage1-vs-Stage4 |
2.429400E-01 |
| Stage2-vs-Stage3 |
3.635600E-01 |
| Stage2-vs-Stage4 |
3.692800E-01 |
| Stage3-vs-Stage4 |
9.307400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.86055640180894E-13 |
| Normal-vs-AfricanAmerican |
3.594400E-04 |
| Normal-vs-Asian |
2.45409999999335E-06 |
| Caucasian-vs-AfricanAmerican |
5.393000E-01 |
| Caucasian-vs-Asian |
5.761800E-01 |
| AfricanAmerican-vs-Asian |
8.642600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29725136083425E-12 |
| Normal-vs-Female |
2.04458672214969E-12 |
| Male-vs-Female |
2.904600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.46120004984596E-09 |
| Normal-vs-Age(41-60Yrs) |
3.95683485976406E-13 |
| Normal-vs-Age(61-80Yrs) |
5.57764945341432E-12 |
| Normal-vs-Age(81-100Yrs) |
2.162200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.681600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.745960E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.756600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.277200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.316000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.689400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.719700E-02 |
| Classical-VS-Follicular |
1.91149999995144E-06 |
| Classical-VS-Other |
2.596000E-01 |
| Classical-VS-Normal |
3.82540000010145E-07 |
| Tall-VS-Follicular |
1.317400E-01 |
| Tall-VS-Other |
7.765600E-01 |
| Tall-VS-Normal |
1.17489999951204E-07 |
| Follicular-VS-Other |
5.631200E-01 |
| Follicular-VS-Normal |
1.85895743243236E-12 |
| Other-VS-Normal |
3.716400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.27515792264421E-14 |
| Normal-vs-N1 |
7.13469949786827E-10 |
| N0-vs-N1 |
6.735800E-01 |
|
|
